Technetium (99mTc) nofetumomab merpentan
| Monoclonal antibody | |
|---|---|
| Type | Fab fragment |
| Source | Mouse |
| Clinical data | |
| Trade names | Verluma |
| ATC code |
|
| Pharmacokinetic data | |
| Elimination half-life | 10.5 hours |
| Excretion | renal (64%) |
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| (what is this?) (verify) | |
Technetium (99mTc) nofetumomab merpentan (trade name Verluma) is a mouse monoclonal antibody derivative used in the diagnosis of lung cancer, gastrointestinal, breast, ovary, pancreas, kidney, cervix, and bladder carcinoma. The antibody part, nofetumomab, is attached to the chelator merpentan, which links it to the radioisotope technetium-99m (99mTc).